SONOVA HOLDING AG UNSP ADR EACH (SONVY) Financials
SONVY Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 5.9 billion | 3.6 billion |
2023-03-31 | 6.1 billion | 3.6 billion |
2022-12-31 | 6.0 billion | 3.6 billion |
2022-09-30 | 5.3 billion | 3.3 billion |
SONVY Free Cash Flow and Stock based compensation
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | 213.2 million | 12.7 million |
2023-03-31 | 480.4 million | 12.1 million |
2022-12-31 | 244.8 million | 6.0 million |
2022-09-30 | 120.1 million | 5.1 million |
SONVY Net Income
Date | Net Income |
---|---|
2023-09-30 | 267.5 million |
2023-03-31 | 389.2 million |
2022-12-31 | 192.3 million |
2022-09-30 | 149.7 million |
SONVY Cash and Debt
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 287.4 million | - | 292.6 million |
2023-03-31 | 453.8 million | - | 324.8 million |
2022-12-31 | 447.9 million | - | - |
2022-09-30 | 299.2 million | - | 269.8 million |
SONVY Shares Outstanding
SONVY Expenses
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 58.0 million | 126.2 million | 178.9 million | 712.5 million |
2023-03-31 | 30.9 million | 135.2 million | 173.2 million | 726.2 million |
2022-12-31 | 15.3 million | 81.7 million | 85.6 million | 359.0 million |
2022-09-30 | 35.2 million | 122.2 million | 158.9 million | 656.7 million |
SONVY Cost of Revenue
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 1.9 billion | 574.0 million |
2023-03-31 | 2.1 billion | 610.6 million |
2022-12-31 | 1.0 billion | 287.1 million |
2022-09-30 | 1.9 billion | 605.2 million |
SONVY
Price: $56.35
Dividend Yield: 0.08%
Forward Dividend Yield: 1.81%
Payout Ratio: 44.40%
Dividend Per Share: 1.02 USD
Earnings Per Share: 2.23 USD
P/E Ratio: 28.20
Exchange: PNK
Sector: Healthcare
Industry: Medical Devices
Volume: 8122
Ebitda: 523.2 millionMarket Capitalization: 16.9 billion
Average Dividend Frequency: 1
Years Paying Dividends: 3